Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,204
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,841
Class I recallsReasonable probability of serious health consequences
24,366
Class II recallsTemporary or medically reversible health consequences
2,892
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,073 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,714 recalls have been announced year to date.
  • Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
  • The highest complete period was Jun 2026 (297).
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,366
Class I9,841
Class III2,892
Not Yet Classified2

Showing 14,401–14,420 of 19,220 recalls

FDA Recall Terminated Historical recordClass II

Ephedrine Sulfate Injection, USP, 50 mg/mL, Single Dose Vial, packaged in a) 1 mL fill in a 2 mL Vial (NDC: 69053-008-01); and b) 25 x 2 mL Vials (NDC 69053-008-02), Rx only, Manufactured for: Andersen Pharmaceutical, White Plains, NY 10605.

by Allergy Laboratories, Inc.

Reason
Lack of Assurance of Sterility: An FDA inspection at the facility raised concerns that product sterility was potentially impacted.
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ondansetron Injection USP 40 mg/20 mL (2 mg/mL), Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454 NDC # 0703-7226-01 (20 mL- Multi-dose Vial), NDC # 0703-72263-03 (10 Multi-dose Vials per carton)

by Teva North America

Reason
CGMP Deviations
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single use vial, For Intravenous Use Only, Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-1179-01.

by Teva North America

Reason
CGMP Deviations
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Linezolid Injection 600 mg/300 mL Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-9060-31- (Single Use Container), NDC# 0703-9060-33 (Box of 10 Singe Use Containers)

by Teva North America

Reason
CGMP Deviations
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ARGATROBAN Injection in 0.9% Sodium Chloride 250 mg/250 mL (1 mg/mL) , Rx Only, Manufactured in Hungary for TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC# 0703-0020-31 (Single Use Bag), NDC # 0703-0020-32 (5 Single Use Bags in One Carton).

by Teva North America

Reason
CGMP Deviations
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Bromocriptine Mesylate Capsules USP, 5 mg, 30-count bottles, Rx only, Manufactured by: Cadila Healthcare ltd., Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-110-06

by Zydus Pharmaceuticals USA Inc

Reason
Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of two batches.
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules CII 30 mg 20 UD Capsules (5 x 4), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH ---- Carton NDC 68084-887-32; Blister NDC 68084-887-33

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules CII 25 mg 20 UD Capsules (5 x 4), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH ---- Carton NDC 68084-909-32; Blister NDC 68084-909-33

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules, CII 20 mg, 30 UD Capsules (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-832-25; Blister NDC 68084-832-95

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules CII 15 mg 20 UD Capsules (5 x 4), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-898-32; Blister NDC 68084-898-33

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended-Release Capsules CII 10 mg 30 UD Capsules (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-815-25; Blister NDC 68084-815-95

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 30 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 60687-154-25; Blister NDC 60687-154-95

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 20 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-943-25; Blister NDC 68084-943-95

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 15 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH ---- Carton NDC 60687-133-25; Blister NDC 60687-133-95

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 10 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH ---- Carton NDC 68084-936-25; Blister NDC 68084-936-95

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 5 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-874-25; Blister NDC 68084-874-95

by Amerisource Health Services

Reason
Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection, 10 mL multidose vial, sterile. Rx only. Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109,

by Isomeric Pharmacy Solution, LLC

Reason
Lack of Processing Controls: Isomeric Pharmacy Solution, LLC announces a voluntary field action for the Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection because the sterile injectable products were sterilized too long leading to potential difficulty resuspending particles.
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Dannon Company, Inc.

Product
Activia FIBER Lowfat Yogurt Strawberry/Pineapple Flavors 12…
Reason
The recalled products are incorrectly labeled because the 12 pack overwrap label includes a "Certified Gluten-Free" mark while the product contains and the overwrap label correctly lists WHEAT as an ingredient.
Published
September 14, 2016
Distribution
Alabama, Arkansas, Arizona, California,…

View recall →

FDA Recall United States Terminated Historical recordClass II

Pharmavite

Product
Nature Made(R) adult gummies Multi for Her plus Omega-3, 150…
Reason
Specific lots of Nature Made(R) product may have possible Salmonella contamination.
Published
September 14, 2016
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

McCain Foods USA

Product
Fire roasted Poblano & Jalapeno popper bites packaged in a w…
Reason
Firm used Flour from General Mills that has been contaminated with E. Coli O121.
Published
September 14, 2016
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.